Literature DB >> 28637537

Occult HIV infection in a large sample of health-care users in Lombardy, Italy in 2014-2015: implications for control strategies.

L Scudeller1, F Genco2, F Baldanti2, G Comolli2, G Albonico3, M Prestia2, V Meroni2.   

Abstract

We estimated the number of people unaware of their human immunodeficiency virus (HIV) infection in our province, Pavia (population 540 000) in Lombardy, Italy, by means of anonymous unlinked testing of 10 044 serum/plasma samples residual from clinical analyses at the outpatient clinic of Policlinico San Matteo in 2014 and 2015. Ethical and legal approval was obtained prior to study start. Samples were irreversibly anonymised, only retaining gender and 5-year age class. Five sample pools were tested for HIV using LIAISON® XL MUREX HIV Ab/Ag (DiaSorin, Saluggia, Italy). If the pool tested positive, individual samples underwent confirmatory tests, Innotest HIV Antigen mAb (Fujirebio Europe, Gent, Belgium) and HIV BLOT 2·2 (MP Diagnostics, Singapore). Among the 10 044 samples processed, eight were confirmed positive (0·08%, 95% confidence interval 0·03-0·16%), all were males and age was >50 in 3 (37·5%). If projected to the entire population of the Pavia province, this would result in approximately 1000 people unaware of their HIV infection, with age older than expected. In Italy, HIV testing is voluntary, universally free-of-charge and (upon request) anonymous. Nevertheless, this study demonstrates that it is suboptimally employed, and that new strategies and population-level actions will be needed to achieve better implementation of HIV testing and HIV control in our province.

Entities:  

Keywords:  Anonymous unlinked HIV testing; ethical issues; human immunodeficiency virus – HIV; infection control; occult HIV infection; public health policy; seroprevalence; surveillance

Mesh:

Year:  2017        PMID: 28637537      PMCID: PMC9148818          DOI: 10.1017/S0950268817001157

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  21 in total

1.  The legality of unlinked anonymous screening for HIV infection: the U.S. approach.

Authors:  L Wan
Journal:  Health Policy       Date:  1990 Jan-Feb       Impact factor: 2.980

2.  Revised guidelines on ethical and legal considerations in anonymous unlinked HIV seroprevalence research. Federal Centre for AIDS Working Group on Anonymous Unlinked HIV Seroprevalence Research.

Authors: 
Journal:  CMAJ       Date:  1992-05-15       Impact factor: 8.262

3.  Human immunodeficiency virus prevalence in women at delivery using unlinked anonymous testing of newborns in the Malaysian setting.

Authors:  H S Amar; J J Ho; A J Mohan
Journal:  J Paediatr Child Health       Date:  1999-02       Impact factor: 1.954

4.  High rates of forward transmission events after acute/early HIV-1 infection.

Authors:  Bluma G Brenner; Michel Roger; Jean-Pierre Routy; Daniela Moisi; Michel Ntemgwa; Claudine Matte; Jean-Guy Baril; Rejéan Thomas; Danielle Rouleau; Julie Bruneau; Roger Leblanc; Mario Legault; Cecile Tremblay; Hugues Charest; Mark A Wainberg
Journal:  J Infect Dis       Date:  2007-02-16       Impact factor: 5.226

5.  Prevalence of undiagnosed HIV infection in the general population having blood tests within primary care in Madrid, Spain.

Authors:  Santiago Moreno; María Ordobás; Juan Carlos Sanz; Belén Ramos; Jenaro Astray; Marta Ortiz; Juan García; Julia del Amo
Journal:  Sex Transm Infect       Date:  2012-05-31       Impact factor: 3.519

6.  The ethics of feedback of HIV test results in population-based surveys of HIV infection.

Authors:  Dermot Maher
Journal:  Bull World Health Organ       Date:  2013-08-23       Impact factor: 9.408

7.  Anonymous unlinked testing as a sentinel approach: experience in Germany.

Authors:  A Siedler; O Hamouda; B Schwartländer
Journal:  J Epidemiol Community Health       Date:  1998-04       Impact factor: 3.710

Review 8.  Diagnosed and undiagnosed HIV-infected populations in Europe.

Authors:  F F Hamers; A N Phillips
Journal:  HIV Med       Date:  2008-07       Impact factor: 3.180

9.  The Unlinked Anonymous HIV Prevalence Monitoring Programme in N. Ireland 1992-1995.

Authors:  C Larkin; R D Maw; P V Coyle; W W Dinsmore; M O McBride; E Mitchell
Journal:  Ulster Med J       Date:  1997-11

10.  Prevalence of Diagnosed and Undiagnosed HIV Infection--United States, 2008-2012.

Authors:  H Irene Hall; Qian An; Tian Tang; Ruiguang Song; Mi Chen; Timothy Green; Jian Kang
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-06-26       Impact factor: 17.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.